Press "Enter" to skip to content

Sanofi to cut U.S. insulin costs for some patients to $99 per month

The cost of insulin for treating type 1 diabetes in the United States has nearly doubled over a five-year period, leading some patients to put their own health at risk by rationing the medication.

Also Read:   Strides develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatment